CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parentheticals) - USD ($) |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Jul. 31, 2017 |
Jul. 31, 2016 |
Jul. 31, 2017 |
Jul. 31, 2016 |
|
Research and Development Expense [Member] | ||||
Non-cash Stock Option Compensation Expenses | $ 64,705 | $ 84,316 | $ 213,333 | $ 171,241 |
Selling and Marketing Expense [Member] | ||||
Non-cash Stock Option Compensation Expenses | $ 416,411 | $ 156,125 | $ 719,440 | $ 398,949 |
X | ||||||||||
- Definition Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|